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Summary
Information on the impact of the COVID-19 pandemic on
pregnancy and breastfeeding experiences, as well as on
perinatal mental health in Switzerland is limited. In
Switzerland, there are few national studies and little in-
formation. Using an anonymous online survey accessible
after the first wave of the outbreak in Switzerland, we
have investigated how this pandemic affected pregnant
and breastfeeding women. Among women who completed
the survey, 69.0% (1050/1518) indicated the first wave of
the pandemic affected their personal habits, 61.0% (689/
1131) were affected in their work and 40.0% (632/1573)
reported impaired relations with healthcare services (dif-
ferent denominators correspond to the number of partic-
ipants who answered the question). 36.8% (110/299) of
women reported an impact of the pandemic on their cur-
rent pregnancy experience or breastfeeding experience
(8.2%, 46/555). Overall, 11.6% (170/1467) of participants
who completed the validated screening tests for mental
health symptoms (Edinburgh Postnatal Depression Scale,
Generalized Anxiety Disorder 7, Perceived Stress
Scale) presented a score compatible with symptoms of
major depression, severe anxiety or high perceived stress,
which is higher than in the pre-pandemic period according
to literature. Risk factors independently associated with
impaired mental health were being hospitalized, having
symptoms of COVID-19, living with a person with
COVID-19 symptoms, having comorbidities, having ex-
perienced reduced healthcare services, having restricted
usual activities and being a housewife. Protective factors
independently associated were a high level of education
and living with a partner. Our findings suggest that the
COVID-19 pandemic might have significantly affected the
well-being and mental health of pregnant and breastfeed-
ing women, directly in the case of exposure, and indirectly
as a result of the potential modifications in their life habits
and in healthcare facilities.
Introduction
Since 11 March 2020, new virus SARS-CoV-2 expansion
from China has been designated as a global pandemic by
the World Health Organization (WHO) [1]. There have
been over 108.2 million cases of the disease related to this
virus (COVID-19) over 2.3 million deaths worldwide as
of 19 February 2021 [2]. Certain categories of the popula-
tion are more vulnerable to this virus, including pregnant
women which have been described as a population at risk
of severe outcomes [3–6]. To slow down the transmission
of the virus, drastic and unprecedented measures were tak-
en in many countries: containment, quarantine, and closure
of schools, workplaces and stores [7]. In Switzerland, these
measures were introduced during the first wave of the pan-
demic, from the middle of March to the end of May 2020
[8].
In addition to professional and financial concerns, preg-
nant and breastfeeding women may have been affected in
their relationship with healthcare professionals and in their
perinatal care, owing to restricted access to hospitals and
postponement of non-urgent care. Furthermore, lack of in-
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formation about this new virus may have generated con-
cerns about maternal and fetal outcomes in the case of in-
fection and could have influenced maternal choices with
regard to personal restrictions, home birthing and breast-
feeding. Such occurrences could have led to psychologi-
cal distress, particularly because this specific population is
vulnerable to mental health problems [9, 10]. According to
the WHO, about 10% of women will experience symp-
toms of depression during pregnancy or post-partum inde-
pendently of the COVID-19 pandemic [11]. Risks factors
known to contribute to antenatal depression are lack of a
partner or social support, unplanned pregnancy, comorbidi-
ties and a history of mental illness, and adverse/unplanned
events modifying life habits [12]. Previous studies have in-
dicated increased rates of depressive symptoms and anxi-
ety among pregnant and breastfeeding women during the
early stages of the COVID-19 pandemic and during quar-
antine [9, 13, 14]. However, the extent to which their ex-
perience of pregnancy and breastfeeding and their mental
health have been affected by the pandemic remains poorly
described. Furthermore, direct (exposure, hospitalisation,
adverse outcomes) and indirect (alteration in personal and
professional habits, access to prenatal care, fears) factors
associated with mental health symptoms during the pan-
demic have not been clearly identified.
The first aim of this study was to describe the potential
association between the changes in the pregnancy/breast-
feeding experience in the COVID-19 pandemic and the
changes related to the healthcare system and life and pro-
fessional habits. The second aim was to describe pregnant
and breastfeeding women’s mental health symptoms dur-
ing the first wave of the pandemic, as well as sociodemo-
graphic, health, exposure and indirect factors contributing
to such mental health symptoms.
Methods
Study design
This Swiss cross-sectional online study is part of a Euro-
pean multicentre study led by the University of Leuven and
conducted in several countries (Belgium, Ireland, Norway,
the Netherlands, the United Kingdom and Switzerland),
with a questionnaire available in German, French and Ital-
ian used in Switzerland. In 2019, 62.1% of Swiss popula-
tion spoke German as their main language, 22.8% French
and 8.0% Italian [15]. The multicentre study aimed to ex-
amine the impact of the COVID-19 pandemic on preg-
nant and breastfeeding women from a broad perspective
(on pregnancy/breastfeeding experience, relationship with
the healthcare system, life and professional habits, person-
al fears, as well as mental health) [16]. In Switzerland, the
questionnaire link was accessible from 18 June to 12 Ju-
ly 2020 through websites and forums dedicated to pregnant
and breastfeeding women: www.letsfamily.ch (German
and French),www.swissmom.ch (German and
French), www.medela.ch (German, French and Italian),
hospital website: www.chuv.ch (French), and social media,
in the form of an advertisement inviting them to partici-
pate. All data were stored and handled anonymously.
Study population
Women aged 18 years or more, pregnant at the time of sur-
vey or who had breastfed during the previous 3 months,
were eligible. The questionnaire was available in the three
predominant national languages in Switzerland and
women from each linguistic region had the opportunity to
be represented.
Variables
The questionnaire was divided in several parts. The first
part collected information on the current pregnancy (gra-
vidity, parity, previous children, pregnancy planning status
and gestational age) or on the infant and breastfeeding sta-
tus (age of the infant, admission to a neonatal intensive
care unit [NICU], change or cessation of breastfeeding be-
cause of SARS-CoV-2, precautions taken during breast-
feeding) according to the situation of the participant. Infor-
mation on how the pandemic influenced their pregnancy/
breastfeeding experience compared with a previous experi-
ence and on how their relationship with healthcare services
had been affected were also collected.
The second part recorded the exposure to COVID-19 using
questions on potential symptoms, testing (reverse tran-
scription polymerase chain reaction [RT-PCR], serology
and/or computed tomography) and COVID-19 related hos-
pitalisation. Fears and beliefs related to the infection were
also gathered (fetal adverse outcomes, willingness to con-
sider abortion in case of early infection).
The third part evaluated personal restrictions and mental
health symptoms using validated screening tests: the Edin-
burgh Postnatal Depression Scale for depression [17, 18],
the Generalized Anxiety Disorder 7-item Scale for anxiety
[19] and the Perceived Stress Scale for stress [20, 21] .
Finally, information on sociodemographic and medical his-
tory was gathered, including country of residence, age, lan-
guage, marital status, working status, education level,
smoking during pregnancy, comorbidities, professional
and financial situation during the pandemic, as well as in-
formation on people living in the same home (number, age
and whether they presented COVID-19 symptoms or had
been tested).
Main outcomes
Impact on pregnancy and breastfeeding experience
The impact of the pandemic on pregnancy or breastfeeding
experience was evaluated through participants’ graded an-
swers: “had a great impact”, “had rather an impact”, “had
little impact” or “had no impact”. Open answers were also
analysed and grouped according to frequently discussed
themes, to illustrate more precisely how the pandemic and
the restrictive measures had had an impact on these preg-
nancy and breastfeeding experiences.
The impact of the pandemic on the relationship with
healthcare systems, on personal and professional habits, on
fears of adverse maternal and fetal/neonatal outcomes were
also assessed through graduated answers.
Impact on perinatal mental health
Women’s mental health was assessed through the validated
screening instruments listed above and was interpreted as
follows:
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1. Edinburgh Postnatal Depression Scale (EPDS) [10, 17,
22–24]: moderate dysphoria (≥10), elevated symptoms
of depression (≥13);
2. Generalized Anxiety Disorder 7 (GAD-7) [19]: pres-
ence of no or minimal symptoms (0–4), presence of
mild symptoms (5–9), presence of moderate symptoms
(10–14), presence of severe symptoms 1 (5-21);
3. Perceived Stress Scale (PSS) [21]: low perceived
stress (0–13), moderate perceived stress (14–26), high
perceived stress (27–40).
Statistical analysis
The prevalence of baseline characteristics and exposure
(COVID-19 testing, symptoms and hospitalisation) was
presented for both pregnant and breastfeeding women. The
impact on their pregnancy and breastfeeding experience
was presented as descriptive statistics. Fears, relationships
with healthcare systems and mental health symptoms were
also presented as descriptive statistics. The scores for de-
pression, anxiety and perceived stress were presented as
minimal/low, mild, moderate and severe/high according to
the definition above.
A nested case-control study was conducted to compare so-
ciodemographic and health characteristics, exposure para-
meters and impacts on personal and professional habits of
pregnant and breastfeeding women, taken together, with
high levels of mental health symptoms, considered as cas-
es, with those of women with low levels of mental health
symptoms, considered as controls. Having symptoms of
severe depression score (EPDS ≥13), having a severe anx-
iety score (GAD-7 ≥15) or experiencing a high perceived
stress score (PSS ≥7) were combined into a unique “poor
mental health” variable for this analysis. These associa-
tions were estimated by univariable and multivariable lo-
gistic regression and were presented as crude odds radio
(ORs) and adjusted odds ratios (aORs) with 95% confi-
dence intervals (95% CIs). Variables were not considered
for the multivariable model if p >0.10 in the univariable
analysis. The association between variables specific to
pregnant or breastfeeding women (gravidity, parity, preg-
nancy planning and current gestational age were asked
only for pregnant women whereas hospitalisation of the
neonate in an NICU was asked only for breastfeeding
mothers) and “poor mental health” was estimated in addi-
tional univariable and multivariable models including only
pregnant and breastfeeding women.
Missing values
Maternal comorbidities were considered as absent if not re-
ported, based on the assumption that severe comorbidities
are normally well documented. Based on the hypothesis of
missing variables completely at random (MCAR), multi-
ple imputations (chained equations) were performed to in-
crease the power of comparisons for missing covariates.
Results
Study population
A total of 2064 respondents participated in the survey
(1161 using the French, 868 the German and 35 the Italian
questionnaires), including 1501 breastfeeding and 563
pregnant women. A total of 369 (17.9%) women did not
complete the questions on the impact of the pandemic on
pregnancy or breastfeeding experience. Therefore, 1695
(82.1%) contributed to the analyses addressing the primary
aim of the study (1136 breastfeeding mothers and 559
pregnant women). Of these, 1467 (86.5%) patients com-
pleted the scales for depression, anxiety or stress, including
980 breastfeeding women and 487 pregnant women (fig.
1).
Baseline characteristics
Baseline characteristics are presented in table 1. The medi-
an age of responders was 33 years and the majority were
married or cohabiting (73.0%). A significant proportion of
women were healthcare providers (18.7%) or housewives
(8.2%). The educational level was high (42.5% had an ed-
ucation level higher than high school) and 12.9% reported
smoking during pregnancy and/or breastfeeding. Less than
5% reported a language different from the official ones.
In total, 8.9% of women reported comorbidities. Among
pregnant women, 94.1% of pregnancies were planned and
the median gestational age at the time the women partic-
ipated in the survey was 28 weeks. In total, 46.5% were
pregnant for the first time. Among the multigravida partic-
ipants, 74.2% had one previous infant and 18.4% had more
than one infant.
SARS-CoV-2 exposure
Overall, 51.7% (877/1695) of participants experienced
symptoms potentially related to COVID-19 in the previous
weeks but only 10.0% (170/1695) were tested and 0.5% (9/
1695) were hospitalized. A total of 156 women were test-
ed with PCR on a nasopharyngeal swab, among them 13
(8.3%) were positive. A serology test was performed in
31 participants and 6 (19.4%) were positive (some partici-
pants received both PCR and serology test). Only 4 women
had a computed tomography scan and 2 (50.0%) were
indicative of COVID-19-related pneumonia. Overall, 302
(17.8%) women indicated living with someone presenting
symptoms potentially related to COVID-19 and only 14
(0.8%) were living with someone tested positive (table 1).
Impact on pregnancy and breastfeeding experiences
Overall, 36.8% (110/299) of pregnant women and 8.2%
(46/555) of breastfeeding women who answered the ques-
tion indicated that the pandemic had “rather an impact”
Figure 1: Flow chart.
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Table 1:
Baseline and pregnancy characteristics, maternal comorbidities and SARS-CoV-2 exposure among 1695 participants.
Pregnant women (n = 559) Breastfeeding mothers (n = 1136) Total ( n = 1695)
Baseline characteristics
Maternal age (years), median (IQR) 33 (31–35) 34 (31–36) 33 (31–36)
Marital status Married / cohabiting 422 (75.5) 815 (71.7) 1237 (73.0)
Single / divorced / other 4 (0.7) 9 (0.8) 13 (0.8)
Unspecified 133 (23.8) 312 (27.5) 445 (26.2)
Working status Healthcare provider 122 (21.8) 195 (17.2) 317 (18.7)
Employed other than HCP 257 (46.0) 465 (40.9) 722 (45.6)
Student 3 (0.5) 7 (0.6) 10 (0.6)
Housewife 21 (3.8) 118 (10.4) 139 (8.2)
Job seeker 12 (2.2) 23 (2.0) 35 (2.1)
Other, unspecified 144 (25.8) 328 (28.9) 472 (27.8)
Educational level Less than high school 9 (1.6) 20 (1.8) 29 (1.7)
High school 75 (13.4) 212 (18.7) 287 (16.9)
More than high school 257 (46.0) 464 (40.9) 721 (42.5)
Other, unspecified 218 (39.0) 440 (38.7) 658 (38.8)
Language other than the official ones 18 (3.2) 61 (5.4) 79 (4.7)
Maternal comorbidities
Any comorbidity 51 (9.1) 100 (8.8) 151 (8.9)
Pulmonary 14 (2.5) 28 (2.5) 42 (2.5)
Cardiovascular 6 (1.1) 11 (1.0) 17 (1.0)
Pregestational diabetes 5 (0.9) 9 (0.8) 14 (0.8)
Thyroid dysfunction 12 (2.1) 27 (2.4) 39 (2.3)
Oncological 1 (0.2) 2 (0.2) 3 (0.2)
Haematological 2 (0.4) 0 (0.0) 2 (0.1)
Autoimmune 2 (0.4) 4 (0.4) 6 (0.4)
Neurological 3 (0.5) 4 (0.4) 7 (0.4)
Psychiatric 3 (0.5) 6 (0.5) 9 (0.5)
Digestive 3 (0.5) 7 (0.6) 10 (0.6)
Urogenital tract 6 (1.1) 15 (1.3) 21 (1.2)
Cutaneous 2 (0.4) 4 (0.4) 6 (0.4)
Ear, nose and throat 0 (0.0) 1 (0.1) 1 (0.1)
Smoking 69 (12.3) 149 (13.1) 218 (12.9)
Current pregnancy
Gravidity 1 266 (46.5)
>1 299 (53.5)
Parity 0 22/298 (7.4)
1 221/298 (74.2)
>1 55/298 (18.4)
Planned pregnancy 526 (94.1)
Getational age (weeks), median (IQR) 28 (18-34)
SARS-CoV-2 exposure
Symptoms 311 (55.6) 566 (49.8) 877 (51.7)
Hospitalized 2 (0.4) 7 (0.6) 9 (0.5)
Tested for SARS-CoV-2 infection 48 (8.6) 122 (10.7) 170 (10.0)
PCR on nasopharyngeal swab 42 (7.5) 114 (10.0) 156 (9.2)
Positive 7/42 (16.7) 6/114 (5.3) 13/156 (8.3)
Negative 34/42 (81.0) 104/114 (91.2) 138/156 (88.5)
Unknown 1/42 (2.3) 4/114 (3.5) 5/156 (3.2)
Serology 10 (1.8) 21 (1.8) 31 (1.8)
Positive 4/10 (40.0) 2/21 (9.5) 6/31 (19.4)
Negative 5/10 (50.0) 16/21 (76.2) 21/31 (67.7)
Unknown 1/10 (10.0) 3/21 (14.3) 4/31 (12.9)
CT scan 2 (0.4) 2 (0.2) 4 (2.4)
Positive 2/2 (100.0) 0/2 (0.0) 2/4 (50.0)
Negative 0/2 (0.0) 2/2 (100.0) 2/4 (50.0)
Living with someone with symptoms 82 (14.7) 220 (19.4) 302 (17.8)
Living with someone tested positive 4 (0.7) 10 (0.9) 14 (0.8)
CT: computed tomography; HCP: healthcare provider; PCR: polymerase chain reaction test
Data are presented as n (%) or median (inter-quartile range [IQR])
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(27.1% and 4.1%, respectively) or “had a great impact”
(9.7% and 4.1%, respectively) on their current pregnancy
experience or breastfeeding experience. Among pregnant
women who specified how the pandemic impacted their
pregnancy, 29/168 (17.3%) and 21/168 (12.5%) indicated
they had “concerns about precautions” to take and experi-
enced “some anxiety during social contact”, respectively.
Among breastfeeding women who specified the impact of
the pandemic in the open question, 9/30 (30.0%) indicat-
ed their breastfeeding experience was an “additional stress
factor” during the pandemic. Among women experiencing
symptoms potentially related to COVID-19, 16.4% (142/
869) indicated that it had directly impaired their mental
health during pregnancy or breastfeeding. Among pregnant
women, 84.0% (432/515) believed maternal COVID-19
can affect the development of the unborn child, but only
3.7% (19/515) would have considered abortion in the event
of maternal infection in early pregnancy. Among breast-
feeding women, only 2.1% (22/1066) had already consid-
ered stopping breastfeeding because of SARS-Cov-2 and
16/172 (9.3%) specified in the open-ended question they
would prefer to “stop earlier to avoid taking risks” (fig. 2.).
A large majority (69.2%; 1050/1518) of both pregnant and
breastfeeding women indicated that the pandemic restrict-
ed their life habits, such as self-imposed strict confine-
ment because of “fear of catching the virus and that it will
endanger breastfeeding”, as an example. A large majori-
ty of pregnant (71,1%; 295/415) and breastfeeding women
(55%; 394/716) mentioned that the COVID-19 pandem-
ic had an impact on their professional life, with negative
(30/42, 71.4%) or positive (12/42, 28.6%) aspects, such as
“positive impact of working from home with less stress
and fatigue from the commuting, and more time to rest”
but also “working from home and no daycare for my
daughter, so it's hard to manage both and enjoy my preg-
nancy at the same time (e.g., shopping for baby)."
A substantial proportion of pregnant (47.5%; 264/556) and
breastfeeding women (36.2%; 368/1017) indicated that the
pandemic affected their interaction with healthcare ser-
vices (fig. 2). Among pregnant women, “restricted visits to
the medical office”, “absence of the father at the medical
office or ultrasounds” and “the absence of care related to
the comfort of pregnancy” were repeated concerns in 42/
168 (25.0%), 70/168 (41.7%) and 16/168 (9.5%) women
who answered the open-ended question, respectively.
Among 172 breastfeeding women, half of them (51.7%,
89/172) reported they received less support during the pan-
demic.
Impact on perinatal mental health
Perinatal mental health measures among pregnant and
breastfeeding women are presented in table 2. A total of
1467 patients completed the EPDS score (487 pregnant
women and 980 breastfeeding women). Results of EPDS
were comparable between pregnant and breastfeeding
women with, in total, 75.8% (1112/1467) reporting no
symptoms of depression, 13.7% (201/1467) symptoms of
moderate dysphoria and 10.5% (154/1467) elevated symp-
toms of depression. Overall, 1422 women completed the
GAD-7 score (468 pregnant women and 954 breastfeeding
women). Results were similar between both groups, with
63.1% (897/1422) of all respondents having a score com-
patible with minimal anxiety, 29.6% (421/1422) mild anx-
iety, 5.7% (81/1422) moderate anxiety and 1.6% (23/1422)
Figure 2: Impact of the COVID-19 pandemic on pregnancies, breastfeeding and relationships with healthcare services
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severe anxiety symptoms. Finally, 1332 participants com-
pleted the PSS with 45.4% (606/1332) receiving a score
compatible with low perceived stress, 51.3% (683/1332)
moderate perceived stress and 3.2% (43/1332) high per-
ceived stress.
Risk factors associated with poor perinatal mental
health
The results of the case-control study that evaluated the
association between women presenting a poor perinatal
mental health status (elevated symptoms of depression, se-
vere anxiety or high perceived stress) and several known
risk factors are presented in table 3. In total, 170 (11.6%)
women (pregnant and breastfeeding together) presented
poor mental health symptoms out of 1467 respondents and
were considered as cases. In the multivariate analysis, be-
ing a housewife (aOR 1.89, 95% CI 1.05–3.43), having
maternal comorbidity (aOR 1.73, 95% CI 1.00–3.01), pre-
senting symptoms potentially related to COVID-19 (aOR
1.69, 95% CI 1.06–2.69), being hospitalized (aOR
5.8, 95% CI 1.41–23.84), living with someone who pre-
sented symptoms (aOR 1.71, 95% CI 1.08–2.70), having
personal habits affected (aOR 2.37, 95% CI 1.37–4.10),
or having restricted access to healthcare services (aOR
2.00, 95% CI 1.30–3.09) were associated with a higher
risk of psychological distress / mental health impairment.
Among breastfeeding women, having a neonate admitted
to a NICU was associated with a higher risk of psycholog-
ical distress / mental health impairment (OR 3.09, 95% CI
1.33–7.19). Protective factors among pregnant and breast-
feeding women were having a high level of education
(aOR 0.56, 95% CI 0.36–0.89), and being married or co-




The first wave of the COVID-19 pandemic had a signif-
icant impact on the current pregnancy or breastfeeding
experiences of one-fifth of the sample of Swiss
women. Two thirds of pregnant and breastfeeding women
restricted their life habits during the first containment pe-
riod in Switzerland in Spring 2020. The pandemic signif-
icantly altered their relationship with healthcare services
according to half of the pregnant women and one third of
the breastfeeding women. More than half of the breastfeed-
ing women felt less supported during this period. More-
over, 11.6% of participants reported significant psycho-
logical distress (symptoms of severe depression, severe
anxiety or high perceived stress). Potential risk factors
associated with poor mental health status were being a
housewife, having comorbidities, presenting symptoms
potentially related to COVID-19, being hospitalized, living
with someone presenting symptoms, having personal
habits affected and having restricted access to healthcare
services. Potential protective factors associated with fewer
symptoms of potential mental health problems were a high
level of education and living with a partner.
Interpretation
The prevalence of symptoms potentially compatible with
COVID-19 among respondents seems to be high in our
sample (54.9%; 806/1467). Some of the symptomatic par-
ticipants may have had other infections indistinguishable
from COVID-19. Surprisingly, a very low proportion of
the participants reported having been tested (10.0%; 170/
1695) despite the high prevalence of reported symptoms.
This might reflect the testing policy at the beginning of the
pandemic, the limited availability of nasopharyngeal RT-
PCR or the reluctance to visit a health facility at the time
of the first wave.
Overall, the rate of Swiss pregnant and breastfeeding
women who reported poor mental health in our survey
(11.6%) is comparable to the 10% of pregnant women
experiencing clinically significant mental health problems
worldwide before the COVID-19 pandemic, according to
the WHO [11] . This rate is also similar to the 11.7% of the
general Swiss population surveyed between 11 May and 1
June 2020, as described by Quervain et al. They noticed
an increase in the prevalence of moderate and severe de-
pressive symptoms compared with the pre-pandemic pe-
riod (3.4%) [25]. However, a few previous studies have
shown that middle- and lower-income countries have a
higher prevalence of poor mental health in the perinatal pe-
riod compared with western countries [26, 27] . In high-
income countries such as Switzerland, 9.5% of women of
childbearing age had moderate or severe major depression
in 2017 [28]. Moreover, we selected only women present-
ing severe mental health symptoms, and therefore have
underestimated the impact of moderate psychological dis-
tress, as found in a study by Wu et al. [29].
In the literature, several studies highlighted similar results
on the impact of the COVID-19 pandemic on perinatal
Table 2:
EPDS (Edinburgh Depression Scale), GAD (General Anxiety Disorder) and PSS (Perceived Stress Scale) scores in 1467 patients.
Pregnant women (n = 487) Breastfeeding mothers (n = 980) p-value
EPDS Minimal (<10) 362 (74.3) 750 (76.5) 0.3546
Moderate (10–12) 74 (15.2) 127 (13.0) 0.2409
Elevated (≥13) 51 (10.5) 103 (10.5) 0.9822
GAD Minimal (0–4) 295/468 (63.0) 602/954 (63.1) 0.9799
Mild (5–9) 146/468 (31.2) 275/954 (28.8) 0.3575
Moderate (10–14) 21/468 (4.5) 60/954 (6.3) 0.1683
Severe (15–21) 6/468 (1.3) 17/954 (1.8) 0.4825
PSS Low (<14) 203/440 (46.1) 403/892 (45.2) 0.7415
Moderate (14–26) 228/440 (51.8) 455/892 (51.0) 0.7811
High (>26) 9/440 (2.0) 34/892 (3.8) 0.0863
Data are presented as n (%); p-values estimated using chi2 tests
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mental health of women living in different countries
[10, 13, 29–34]. Most of them focused on pregnant women
who experienced a range of disorders, such as anxiety,
symptoms of depression and sleep disturbances during the
COVID-19 pandemic. Extreme changes in daily life have
been associated with an increased risk of depression, in
line with our findings [30] . However, it is interesting to
note that in our results, a quarter of the women indicating
that the pandemic has had an impact on their daily lives
described a positive impact, particularly the implementa-
tion of “working from home”, which reduced their stress
and fatigue. Low education level and working part-time or
less were risk factors for depression according to Wu et
al. [29]. This supports our finding of a high educational
level as a protective factor for psychological distress and
being a housewife as a risk factor. Low familial support
could participate in developing a depression [29], just as
having good social support seems protective against stress
[10, 35]. This is in line with our finding of a possible
protective effect of being married / cohabiting. Changes in
prenatal care during the confinement period has been de-
picted as a stress factor by Preis et al. [36] which seems in
accordance with the impact of restricted access to health-
care services on perinatal mental health in our study.
Among the general Chinese population, having confirmed
or suspected COVID-19 or having relatives with con-
firmed or suspected COVID-19 were factors associated
with poor mental health according to Shi et al. [37] , in line
with our findings. Future studies might investigate the role
of other protective factors against stress and depression,
such as adequate sleep duration [10] and regular physical
activity [29, 36] .
During the pandemic, a higher percentage of women with
thoughts of self-harm has been found in China [29]. More-
over, mental health issues have a severe impact on quality
of life, social and partner relationships and on child devel-
opment [38, 39]. Therefore, future searches for effective
interventions to manage potential psychological distress
among pregnant and breastfeeding women are urgently
needed. Psychological first aid and telehealth could be ap-
propriate tools to support pregnant and breastfeeding
women with mental health problems during outbreaks
[40].
Strengths and limitations
The large number of participants and the fact that the sur-
vey was performed in three official languages (women
from different parts of Switzerland were reached) are im-
portant strengths of the present study. The content analysis
Table 3:
Factors associated with an altered mental health status in 1467 patients.
Baseline characteristics Women with altered mental health sta-
tus
Women with normal mental health sta-
tus
OR (95% CI) aOR
d
(95% CI)
n = 170 11.6% n = 1297 88.4%
Baseline characteristics
Maternal age >40 years 10 (5.9) 72 (5.6) 1.06 (0.54–2.10)
Married or cohabiting 142/146a (97.3) 1095/1104a (99.2) 0.29a (0.08–0.96) 0.20 (0.04–1.12)
Healthcare provider 33 (19.4) 284 (21.9) 0.85 (0.57–1.28)
Housewife 26 (15.3) 113 (8.7) 1.89 (1.19–2.99) 1.89 (1.05–3.43)
Educational level >high school 70/117* (59.8) 651/920* (70.8) 0.61 (0.41–0.94) 0.56 (0.36–0.89)
Language other than the official ones 9/146* (6.2) 70/1104 (6.3) 0.97 (0.47–1.99)
Any maternal comorbidity 28 (16.5) 123 (9.5) 1.88
Smoking 32 (18.8) 186 (14.3) 1.38 (1.21–2.94) 1.73 (1.00–3.01)
Current pregnancy
First pregnancy 27/53b (50.9) 202/434b (46.5) 1.19 (0.67–2.11)
Previous children 51/53b (96.2) 417/434b (96.1) 1.03 (0.23–4.63)
Planned pregnancy 49/53b (92.5) 408/434b (94.0) 0.78 (0.26–2.33)
Gestational age 1st trimester 9/53b (17.0) 65/434b (15.0) 1.11 (0.45–2.43)
2nd trimester 20/53b (37.7) 166/434b (38.2) 0.85 (0.37–1.98)
3rd trimester 24/53b (45.3) 203/434b (46.8) 0.84 (0.37–1.90)
Neonate admitted in NICU 8/117c (6.8) 20/863c (2.3) 3.09 (1.33–7.19)
SARS-COV-2 exposure
Symptoms 114 (67.1) 692 (53.4) 1.78 (1.27–2.50) 1.69 (1.06–2.69)
Hospitalized for COVID-19 5 (2.9) 4 (0.3) 9.80 (2.60–38.84) 5.80 (1.41–23.84)
Tested positive for SARS-COV-2 on RT-
PCR
1 (0.6) 11 (0.8) 0.69 (0.09–5.39)
Living with someone with symptoms 48 (28.2) 254 (19.6) 1.61 (1.12–2.31) 1.71 (1.08–2.70)
Living with someone tested positive 1 (0.6) 13 (1.0) 0.58 (0.08–4.50)
Impact of the SARS-COV-2 pandemic on
Professional situation 77/128a (60.2) 612/1003a (61.0) 0.96 (0.66–1.40)
Life habits 143 (84.1) 875 (67.5) 2.55 (1.67–3.92) 2.37 (1.37–4.10)
Relationship with healthcare systems 88/159a (55.3) 473/1240a (38.1) 2.00 (1.44–2.80) 2.00 (1.30–3.09)
aOR: adjusted odds ratio; CI: confidence interval; OR: odds ratio; RT-PCR: reverse transcription polymerase chain reaction
a Multiple imputations were performed on missing values, for variables with a denominator different from the overall denominator
b Tested only in pregnant women
c Tested only in breastfeeding women
d Only significant risk factors have been included in the multivariable analysis
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of the open-ended quotations provides a good overview of
the reality of these women during this outbreak.
However, sociodemographic characteristics of the partici-
pants differ from those presented by the official Swiss sta-
tistics (appendix), particularly regarding age distribution,
professional activity and education. Women who partici-
pated in our survey seem to be more representative of a
population over 26 years of age, with a high level of educa-
tion and a high activity rate, preventing the generalisation
of these results to the general population of Swiss pregnant
and breastfeeding women. Although Swiss women do have
good internet access (95%) [15], selection bias in favour
of more motivated or concerned women could have oc-
curred, as the survey was online. Women seeking infor-
mation about their pregnancy or breastfeeding were more
likely to encounter the online survey than less worried
women. They may represent a more educated population of
website users. The high proportion of healthcare providers
participating in this survey (18.7%) may also represent a
more educated population, leading to a potential selection
bias for a protective factor for mental health, which could
underestimate the prevalence of psychological distress. Se-
verely ill women were most probably not included as they
would not have the capacity to participate. In our survey,
4.7% of respondents indicated speaking another language
as main language, whereas a higher proportion (17.7%) of
people living in Switzerland report speaking language oth-
er than the official ones [28] . Therefore, it is possible that
the immigrant population was underrepresented. The high
proportion of French-speaking answers compared with the
proportion of Swiss people who speak French as their pri-
mary language (23%) could reflect a selection bias, part-
ly explained by the fact that the distribution of the survey
was initiated by the CHUV (Centre Hospitalier Universi-
taire Vaudois, university hospital of the biggest French-
speaking canton) [15]. Another explanation may be that the
French-speaking part of Switzerland has been more seri-
ously affected by the pandemic than the German-speaking
part [41]. This may have led to an overrepresentation of
one of the linguistic regions.
A limitation could be the fact that symptoms could not
specifically be assigned to SARS-CoV-2 infection.
The mental health scores only measure depressive symp-
toms, anxiety and stress experienced over the last 4 weeks,
preventing us from drawing any conclusions on mental
health status during the peak of the first pandemic wave.
The study was a cross-sectional study and no information
was collected on the long-term impact of the pandemic on
mental health and perinatal experiences.
The drop-out from the survey (17.9%) could be attributed
to the length of the questionnaire, with a certain proportion
of open-ended questions. Some questions might have also
triggered emotions (fear, irritability or feeling misunder-
stood, for example) and might thus have been skipped by
participants, selecting women with a lower risk of psycho-
logical distress, thus violating the assumption of informa-
tion missing at random. Finally, recall bias as a result of
better recall among women with stronger negative experi-
ences due to the pandemic cannot be excluded.
Conclusion
Our findings suggest that the first wave of the COVID-19
pandemic may have had a severe impact on the mental
health and perinatal experiences of pregnant and breast-
feeding women in Switzerland, both directly through expo-
sure to SARS-CoV-2, and indirectly through the impact on
their life habits and contact with healthcare facilities. Pre-
vention and support strategies should be set-up to counter
these consequences of the COVID-19 epidemic for mater-
nal-child health.
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Appendix: Supplementary table
Table S1:
Comparison between the general birthing population and the study sample of pregnant and breastfeeding women in Switzerland.
General population* Pregnant (n = 563) Lactation (n = 1193)
Maternal age (years) 18–25 8.1 2.8 1.7
26–30 26.4 25.1 20.5
31–35 39.3 47.5 49.7
36–40 21.8 22.0 23.1
>40 4.4 2.6 4.9
Parity Nulliparous 45.3 51.1 N/A
Multiparous 54.7 48.9 N/A
Professional status Professionally active 83.0 91.0 81.7
Highest education level Low 42.7 25.7 33.1
Medium 12.0 23.4 17.8
High 45.3 50.9 49.1
Smoking in pregnancy Yes 7.0 5.9 N/A
No 93.0 94.1 N/A
Data are presented as %. N/A: not available
* Statistics for the general birthing population in Switzerland were retrieved from the Federal Statistical Office (FSO) in 2019 for maternal age, professional status (aged 25–54
years), education level (aged 25–34 years) and 2018 for parity (aged 25–44 years) (https://www.bfs.admin.ch). Smoking in pregnancy in Switzerland has been monitored on
behalf of FSO between 2011 and 2016 (https://www.infoset.ch/fr/tabac.html ).
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